Eylea 2 MG/0.05 ML vial 0.05ML
Ended Awarded
- Contract number
- SPE2DB25FUJNX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,770
Award facts
- Contract value 100% obligated
- $3,770.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,770.31 by the Defense Logistics Agency for the supply of EYLEA 2 mg/0.05 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 12, 2025. This award carries no set-aside designation, allowing the vendor to compete on a competitive basis leveraging its woman-owned small business status. The product being delivered—EYLEA (aflibercept), a prescription medication used in ophthalmology—will be distributed to medical facilities, with performance occurring at the company's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. This master contract authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. The company has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering prescription medications, biologics, vaccines, and medical consumables. The current award represents a discrete transaction within this broader framework, fulfilling specific pharmaceutical requirements for military health system operations.
Quick answers
Who was awarded contract SPE2DB25FUJNX?
SPE2DB25FUJNX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 21, 2025.
How much is contract SPE2DB25FUJNX worth?
The government has obligated $3,770 on SPE2DB25FUJNX.
Is contract SPE2DB25FUJNX an order under another contract?
Yes. SPE2DB25FUJNX is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJNX competed?
The extent of competition for SPE2DB25FUJNX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award